Compare CIGL & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIGL | NRC |
|---|---|---|
| Founded | 1997 | 1981 |
| Country | Singapore | United States |
| Employees | 134 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.7M | 390.8M |
| IPO Year | N/A | 1997 |
| Metric | CIGL | NRC |
|---|---|---|
| Price | $1.80 | $17.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 82.2K | ★ 89.7K |
| Earning Date | 05-15-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.73% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.34 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $1.40 | $9.76 |
| 52 Week High | $25.00 | $22.79 |
| Indicator | CIGL | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 56.63 |
| Support Level | $1.55 | $14.48 |
| Resistance Level | $2.28 | $17.22 |
| Average True Range (ATR) | 0.22 | 0.87 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 34.25 | 38.50 |
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.